Karyopharm Therapeutics Inc. (KPTI) vs Pulsenmore Ltd. Ordinary Shares (PLSM)
A side-by-side comparison of Karyopharm Therapeutics Inc. and Pulsenmore Ltd. Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KPTI
Karyopharm Therapeutics Inc.
$0.71HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
PLSM
Pulsenmore Ltd. Ordinary Shares
$2.20HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
Total return — KPTI vs PLSM
growth of $100 · dividends reinvested · last 1yKPTI -89.4% (-89.4%/yr)PLSM -70.0% (-70.0%/yr)PLSM compounded faster over this window
KPTI PLSM
KPTI vs PLSM: by the numbers
- •KPTI is the larger company ($16M vs $14M market cap).
- •Both run net losses; PLSM's is the smaller (-39.61% vs -153.28% net margin).
Metrics side by side
Valuation
| Metric | KPTI | PLSM |
|---|---|---|
| P/S ratio | 0.11 | N/A |
| P/B ratio | N/A | 0.87 |
Profitability
| Metric | KPTI | PLSM |
|---|---|---|
| Gross margin | 95.88% | 84.15% |
| Operating margin | -56.17% | -30.39% |
| Net margin | -153.28% | -39.61% |
| ROE | N/A | -19.08% |
| ROIC | N/A | -13.15% |
Growth (annualized)
| Metric | KPTI | PLSM |
|---|---|---|
| Revenue CAGR (5Y) | 7.47% | N/A |
| Total return CAGR (5Y) | -62.18% | N/A |
Go deeper
Dig into the metrics
Karyopharm Therapeutics ROEPulsenmore Ltd. Ordinary Shares ROEKaryopharm Therapeutics operating marginPulsenmore Ltd. Ordinary Shares operating marginKaryopharm Therapeutics revenue growthPulsenmore Ltd. Ordinary Shares revenue growthKaryopharm Therapeutics free cash flowPulsenmore Ltd. Ordinary Shares free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.